In the BioHarmony Drug Report Database

"Preview" Icon

Pyridostigmine

Mestinon, Pyridostigmine Bromide, Regonol (pyridostigmine) is a small molecule pharmaceutical. Pyridostigmine was first approved as Mestinon on 1982-01-01. It is used to treat drug-induced abnormalities and myasthenia gravis in the USA. It is known to target acetylcholinesterase and cholinesterase.

 

Trade Name

 

Mestinon, Pyridostigmine Bromide, Regonol
 

Common Name

 

pyridostigmine
 

ChEMBL ID

 

CHEMBL1115
 

Indication

 

drug-induced abnormalities, myasthenia gravis
 

Drug Class

 

Cholinesterase inhibitors (physostigmine type)

Image (chem structure or protein)

Pyridostigmine structure rendering